Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
315
Views
75
CrossRef citations to date
0
Altmetric
Original

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia

M. J. Greenwood The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
M. D. Seftel The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
C. Richardson The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
D. Barbaric The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
M. J. Barnett The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
H. Bruyere The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
D. L. Forrest The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
D. E. Horsman The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
C. Smith The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
K. Song The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
H. J. Sutherland The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
C. L. Toze The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
T. J. Nevill The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
,
S. H. Nantel The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
&
D. E. Hogge The Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology and Hematopathology, Vancouver General Hospital, BC Cancer Agency and the University of British Columbia, Vancouver, BC, CanadaCorrespondence[email protected]
 show all
Pages 1245-1252 | Received 02 Sep 2005, Accepted 02 Jan 2006, Published online: 01 Jul 2009

Citations (75)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Andrés Gómez-De León, Roberta Demichelis-Gómez, Abel da Costa-Neto, David Gómez-Almaguer & Eduardo Magalhães Rego. (2023) Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America. Hematology 28:1.
Read now
Walid Macaron, Zaven Sargsyan & Nicholas J. Short. (2022) Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leukemia & Lymphoma 63:8, pages 1780-1791.
Read now
Ikhwan Rinaldi, Melva Louisa, Resti Mulya Sari & Elly Arwanih. (2021) FLT3-ITD Mutation and FLT3 Ligand Plasma Level Were Not Associated with One-Year Survival of Indonesian Acute Myeloid Leukemia Patients. OncoTargets and Therapy 14, pages 1479-1486.
Read now
Rory M. Shallis, Maximilian Stahl, Jan Philipp Bewersdorf, Jeanne E. Hendrickson & Amer M. Zeidan. (2020) Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits. Expert Review of Hematology 13:5, pages 489-499.
Read now
Lu-Hong Xu, Jing-Wen Wang, Yin Wang & Feng-Ying Yang. (2020) Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia. Hematology 25:1, pages 507-514.
Read now
Xinyu Nan, Qian Qin, Cesar Gentille, Joe Ensor, Christopher Leveque, Sai R. Pingali, Alexandria T. Phan, Lawrence Rice & Swaminathan Iyer. (2017) Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis – a retrospective study from a tertiary center. Leukemia & Lymphoma 58:9, pages 2110-2117.
Read now
Sabrina Giammarco, Patrizia Chiusolo, Nicola Piccirillo, Alessia Di Giovanni, Elisabetta Metafuni, Luca Laurenti, Simona Sica & Livio Pagano. (2017) Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Review of Hematology 10:2, pages 147-154.
Read now
Anne-Claire Mamez, Emmanuel Raffoux, Sylvie Chevret, Virginie Lemiale, Nicolas Boissel, Emmanuel Canet, Benoît Schlemmer, Hervé Dombret, Elie Azoulay & Etienne Lengliné. (2016) Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leukemia & Lymphoma 57:10, pages 2281-2288.
Read now
Ryoko Mabuchi, Takeshi Hara, Takuro Matsumoto, Yuhei Shibata, Nobuhiko Nakamura, Hiroshi Nakamura, Junichi Kitagawa, Nobuhiro Kanemura, Naoe Goto, Masahito Shimizu, Hiroyasu Ito, Yasuko Yamamoto, Kuniaki Saito, Hisataka Moriwaki & Hisashi Tsurumi. (2016) High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia. Leukemia & Lymphoma 57:1, pages 92-98.
Read now
Nicolas Duployez, Christophe Willekens, Alice Marceau-Renaut, Elise Boudry-Labis & Claude Preudhomme. (2015) Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors. Expert Review of Hematology 8:1, pages 43-56.
Read now
Etienne Lengliné, Emmanuel Raffoux, Virginie Lemiale, Michael Darmon, Emmanuel Canet, Nicolas Boissel, Benoît Schlemmer, Hervé Dombret & Elie Azoulay. (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leukemia & Lymphoma 53:7, pages 1352-1359.
Read now
Murtadha Al-Khabori, Mark D. Minden, Karen W.L. Yee, Vikas Gupta, Aaron D. Schimmer, Andre C. Schuh, Wei Xu & Joseph M. Brandwein. (2010) Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia. Leukemia & Lymphoma 51:1, pages 61-65.
Read now
Apostolia-Maria Tsimberidou & Elihu Estey. (2006) Induction mortality risk in adult acute myeloid leukemia. Leukemia & Lymphoma 47:7, pages 1199-1200.
Read now

Articles from other publishers (62)

Aoli Zhang, Lipeng Liu, Suyu Zong, Lixian Chang, Xiaojuan Chen, Wenyu Yang, Ye Guo, Li Zhang, Yao Zou, Yumei Chen, Yingchi Zhang, Min Ruan & Xiaofan Zhu. (2023) Pediatric acute myeloid leukemia and hyperleukocytosis with WBC count greater than 50 × 109/L. International Journal of Hematology 118:6, pages 737-744.
Crossref
Fernando Ramos, María Lourdes Hermosín, Marta Fuertes-Núñez, Pilar Martínez, Carlos Rodriguez-Medina, Manuel Barrios, Francisco Ibáñez, Teresa Bernal, Maria Teresa Olave, Miguel Ángel Álvarez, María Vahí, Teresa Caballero-Velázquez, Bernardo González, Albert Altés, Lorena García, Pascual Fernández, María Antonia Durán, Rocío López, Montserrat Rafel & Josefina Serrano. (2023) Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice. Journal of Personalized Medicine 13:12, pages 1667.
Crossref
Yujiao Zhang, Quan Wu, Baoyi Yuan, Yun Huang, Ling Jiang, Fang Liu, Ping Yan, Yongshuai Jiang, Jieyu Ye & Xuejie Jiang. (2023) Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia. BMC Cancer 23:1.
Crossref
Laura Jimbu, Madalina Valeanu, Trifa Adrian, Oana Mesaros, Anca Bojan, Delia Dima, Andrada Parvu, Ioana C Rus, Ciprian Tomuleasa, Tunde Torok, Laura Urian, Anca Vasilache & Mihnea Zdrenghea. (2023) A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience. Cureus.
Crossref
Sofiane Fodil, Marine Arnaud, Camille Vaganay, Alexandre Puissant, Etienne Lengline, Nuala Mooney, Raphael Itzykson & Lara Zafrani. (2022) Endothelial cells: major players in acute myeloid leukaemia. Blood Reviews 54, pages 100932.
Crossref
Kunhwa Kim, Marina Konopleva, Courtney D. DiNardo, Gautam Borthakur, Sanam Loghavi, Guilin Tang, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Caitlin R. Rausch, Musa Yilmaz, Koji Sasaki, Nicholas J. Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop Kantarjian & Tapan M. Kadia. (2022) Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American Journal of Hematology 97:7, pages 885-894.
Crossref
Delphine Bréchemier, Marie Garric & Thomas De Nadaï. 2022. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine 331 341 .
Henan Zhang, Yue Zhao, Xuan Liu, Yusi Liu, Xiaohui Wang, Yu Fu, Shuang Fu & Jihong Zhang. (2021) A novel upregulated LncRNA‐AC026150.8 promotes chemo‐resistance and predicts poor prognosis in acute myeloid leukemia. Cancer Medicine 10:23, pages 8614-8629.
Crossref
Mesut Göçer & Erdal Kurtoğlu. (2021) Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis. Therapeutic Apheresis and Dialysis 25:5, pages 697-703.
Crossref
Howon Lee, Silvia Park, Jae-Ho Yoon, Byung-Sik Cho, Hee-Je Kim, Seok Lee, Dong-Wook Kim, Nack-Gyun Chung, Bin Cho, Kyoung Bo Kim, Jaeeun Yoo, Dong Wook Jekarl, Hyojin Chae, Jihyang Lim, Myungshin Kim, Eun-Jee Oh & Yonggoo Kim. (2021) The factors influencing clinical outcomes after leukapheresis in acute leukaemia. Scientific Reports 11:1.
Crossref
Merve PAMUKCUOGLU & Mehmet Sezgin PEPELER. (2020) Hiperlökositoz Bulgusu ile Başvuran Akut Myelositer Lösemili Olgularda Lökoferez, Hidroksiüre ve Steroid Tedavilerinin Geriye Dönük Olarak Birbiri ile KarşılaştırılmasıA Retrospective Comparison of Leukapheresis, Hydroxyurea and Steroid Therapies in Patients with Acute Myelocytic Leukemia who Present with Hyperleukocytosis. Harran Üniversitesi Tıp Fakültesi Dergisi 17:3, pages 401-405.
Crossref
Maximilian Stahl, Rory M. Shallis, Wei Wei, Pau Montesinos, Etienne Lengline, Judith Neukirchen, Vijaya R. Bhatt, Mikkael A. Sekeres, Amir T. Fathi, Heiko Konig, Selina Luger, Irum Khan, Gail J. Roboz, Thomas Cluzeau, David Martínez-Cuadron, Emmanuel Raffoux, Ulrich Germing, Jayadev Manikkam Umakanthan, Sudipto Mukherjee, Andrew M. Brunner, Adam Miller, Christine M. McMahon, Ellen K. Ritchie, Rebeca Rodríguez-Veiga, Raphaël Itzykson, Blanca Boluda, Florence Rabian, Mar Tormo, Evelyn Acuña-Cruz, Emma Rabinovich, Brendan Yoo, Isabel Cano, Nikolai A. Podoltsev, Jan Philipp Bewersdorf, Steven Gore & Amer M. Zeidan. (2020) Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia 34:12, pages 3149-3160.
Crossref
Sangappa Shanker Rao, Ajay Sharma & Niket Verma. (2020) Risk Stratification in Patients of Acute Leukaemia Presenting to a Tertiary Care Hospital in North India. Journal of Evidence Based Medicine and Healthcare 7:27, pages 1306-1311.
Crossref
Thanh H. Nguyen, Khanh Q. Bach, Hung Q. Vu, Nhat Q. Nguyen, Thien D. Duong, Stef De Reys & Jennifer Wheeler. (2019) Pre‐chemotherapy white blood cell depletion by therapeutic leukocytapheresis in leukemia patients: A single‐institution experience. Journal of Clinical Apheresis 35:2, pages 117-124.
Crossref
I. I. Kalinina, N. V. Zacharov, D. A. Venev, T. Yu. Salimova, U. N. Petrova, O. V. Goronkova, D. D. Baydildina, E. V. Suntcova, M. N. Sadovskay, D. A. Evseev, V. E. Matveev, K. S. Antonova, I. G. Khamin, M. E. Dubrovina, Yu. V. Olshanskaya, E. A. Zerkalenkova, A. I. Mandgieva, D. N. Balashov, L. N. Shelikhova, M. A. Maschan, G. A. Novichkova & A. A. Maschan. (2020) The results of treatment in children with AML and initial hyperleucocytosis according to the AML-MM-2006 Protocol. Pediatric Hematology/Oncology and Immunopathology 19:1, pages 9-17.
Crossref
Abdulkerim Yıldız, Senem Maral, Murat Albayrak, Çiğdem Pala, Pınar Cömert, Hacer Berna Afacan Öztürk & Osman Şahin. (2020) Are the conventional risk factors still valid for acute myeloid leukemia patients?. Konuralp Tıp Dergisi, pages 5-11.
Crossref
Chia‐Jen Liu, Ying‐Chung Hong, Ai Seon Kuan, Chiu‐Mei Yeh, Chun‐Kuang Tsai, Yao‐Chung Liu, Liang‐Tsai Hsiao, Hao‐Yuan Wang, Po‐Shen Ko, Po‐Min Chen, Jin‐Hwang Liu & Jyh‐Pyng Gau. (2020) The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia. Cancer Medicine 9:4, pages 1572-1580.
Crossref
Lohith Gowda & Chitra Hosing. 2020. Oncologic Critical Care. Oncologic Critical Care 1147 1153 .
Rita Assi & Nicholas Short. 2020. Oncologic Critical Care. Oncologic Critical Care 1135 1145 .
Takashi Ishihara, Keiji Nogami, Tomoko Onishi, Kenichi Ogiwara, Satoshi Ochi, Masaharu Yamazaki & Midori Shima. (2019) Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation. Pediatrics International 61:9, pages 872-881.
Crossref
Gursel Gunes, Hakan Goker, Haluk Demiroglu, Umit Yavuz Malkan & Yahya Buyukasik. (2018) Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors. Bone Marrow Transplantation 54:4, pages 595-600.
Crossref
Lohith Gowda & Chitra Hosing. 2019. Oncologic Critical Care. Oncologic Critical Care 1 7 .
Rita Assi & Nicholas Short. 2019. Oncologic Critical Care. Oncologic Critical Care 1 11 .
Yanxia Jin, Shishang Guo, Qin Cui, Sichao Chen, Xiaoping Liu, Yongchang Wei, Yunbao Pan, Liang Tang, Tingting Huang, Hui Shen, Guanghui Xu, Xuelan Zuo, Shangqin Liu, Hui Xiao, Fei Chen, Fayun Gong & Fuling Zhou. (2018) A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia. Scientific Reports 8:1.
Crossref
Umit Yavuz Malkan & Osman Ilhami Ozcebe. (2017) Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis. Transfusion and Apheresis Science 56:6, pages 880-882.
Crossref
Bernward Zeller, Heidi Glosli, Erik Forestier, Shau-Yin Ha, Kirsi Jahnukainen, Ólafur G. Jónsson, Birgitte Lausen, Josefine Palle, Henrik Hasle & Jonas Abrahamsson. (2017) Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10 9 /l. The NOPHO experience 1984-2014 . British Journal of Haematology 178:3, pages 448-456.
Crossref
Jonathan Canaani, Myriam Labopin, Gerard Socié, Anne Nihtinen, Anne Huynh, Jan Cornelissen, Eric Deconinck, Tobias Gedde-Dahl, Edouard Forcade, Patrice Chevallier, Jean H. Bourhis, Didier Blaise, Mohamad Mohty & Arnon Nagler. (2017) Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT. American Journal of Hematology 92:7, pages 653-659.
Crossref
Lisa Pleyer, Hartmut Döhner, Hervé Dombret, John Seymour, Andre Schuh, CL Beach, Arlene Swern, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Heinz Sill, Konstantin Schlick, Josef Thaler, Britta Halter, Sigrid Machherndl Spandl, Armin Zebisch, Angelika Pichler, Michael Pfeilstöcker, Eva Autzinger, Alois Lang, Klaus Geissler, Daniela Voskova, Wolfgang Sperr, Sabine Hojas, Inga Rogulj, Johannes Andel & Richard Greil. (2017) Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group. International Journal of Molecular Sciences 18:2, pages 415.
Crossref
Alaa M. Ali, Aibek E. Mirrakhimov, Camille N. Abboud & Amanda F. Cashen. (2016) Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest. Hematological Oncology 34:2, pages 69-78.
Crossref
Ursula Creutzig, Claudia Rössig, Michael Dworzak, Jan Stary, Arend von Stackelberg, Wilhelm Wössmann, Martin Zimmermann & Dirk Reinhardt. (2016) Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis. Pediatric Blood & Cancer 63:4, pages 640-645.
Crossref
Pulkit Rastogi, Shano Naseem, Neelam Varma & Subhash Varma. (2015) Nucleophosmin mutation in de‐novo acute myeloid leukemia. Asia-Pacific Journal of Clinical Oncology 12:1, pages 77-85.
Crossref
Banseok KimKyongae LeeSinyoung KimHyun Ok Kim. (2016) Therapeutic Leukapheresis for the Management of Hyperleukocytosis: Ten-year Experience in a Tertiary Care Hospital. Laboratory Medicine Online 6:3, pages 159.
Crossref
Lovisa Wennström, Pernille Wendtland Edslev, Jonas Abrahamsson, Jan Maxwell Nørgaard, Yngvar Fløisand, Erik Forestier, Göran Gustafsson, Jesper Heldrup, Liisa Hovi, Kirsi Jahnukainen, Olafur Gisli Jonsson, Birgitte Lausen, Josefine Palle, Bernward Zeller, Erik Holmberg, Gunnar Juliusson, Dick Stockelberg & Henrik Hasle. (2016) Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries. Pediatric Blood & Cancer 63:1, pages 83-92.
Crossref
Daniela Damiani, Mario Tiribelli, Donatella Raspadori, Santina Sirianni, Alessia Meneghel, Margherita Cavalllin, Angela Michelutti, Eleonora Toffoletti, Antonella Geromin, Erica Simeone, Monica Bocchia & Renato Fanin. (2015) Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors. Oncotarget 6:30, pages 30212-30221.
Crossref
Kazunori Nakase, Kenkichi Kita, Taiichi Kyo, Takanori Ueda, Isao Tanaka & Naoyuki Katayama. (2015) Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor ?-Chain (CD25) Expression Predicts a Poor Prognosis. PLOS ONE 10:9, pages e0128998.
Crossref
Li Yingchun, Zhang Rong, Yao Kun, Yang Ying & Liu Zhuogang. (2015) Bone Marrow MicroRNA-335 Level Predicts the Chemotherapy Response and Prognosis of Adult Acute Myeloid Leukemia. Medicine 94:33, pages e0986.
Crossref
Kevin H. M. Kuo, Jeannie L. Callum, Tony Panzarella, Lindsay M. Jacks, Joseph Brandwein, Michael Crump, John E. Curtis, Vikas Gupta, Jeffrey H. Lipton, Mark D. Minden, Graham D. Sher, Aaron D. Schimmer, Andre C. Schuh, Karen W. L. Yee, Armand Keating & Hans A. Messner. (2015) A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. British Journal of Haematology 168:3, pages 384-394.
Crossref
Nicole Aqui & Una O'Doherty. (2014) Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia. Hematology 2014:1, pages 457-460.
Crossref
Debora Capelli, Martina Chiarucci, Antonella Poloni, Francesco Saraceni, Giorgia Mancini, Silvia Trappolini, Emanuela Troiani, Mauro Montanari, Ilaria Scortechini, Massimo Offidani, Serena Rupoli, Anna Rita Scortechini, Guido Gini, Giancarlo Discepoli, Pietro Leoni & Attilio Olivieri. (2014) Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin. Biology of Blood and Marrow Transplantation 20:9, pages 1399-1406.
Crossref
Sapna Oberoi, Thomas Lehrnbecher, Bob Phillips, Johann Hitzler, Marie-Chantal Ethier, Joseph Beyene & Lillian Sung. (2014) Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis. Leukemia Research 38:4, pages 460-468.
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzOta Fuchs. 2014. Cancer Biomarkers. Cancer Biomarkers 813 848 .
Davood Zare-Abdollahi, Shamsi Safari, Abolfazl Movafagh, Mojtaba Ghadiani, Sahand Riazi-Isfahani & Mir Davood Omrani. (2013) Intact expression status of RASSF1A in acute myeloid leukemia. Medical Oncology 31:1.
Crossref
Ø. Bruserud, K. Liseth, S. Stamnesfet, D. L. Cacic, G. Melve, E. Kristoffersen, T. Hervig & H. Reikvam. (2013) Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfusion Medicine 23:6, pages 397-406.
Crossref
Fatih Kurnaz, Serdar Sivgin, Cigdem Pala, Rahsan Yildirim, Suleyman Baldane, Leylagul Kaynar, Musa Solmaz, Ahmet Ozturk, Bulent Eser, Mustafa Cetin & Ali Unal. (2013) The effect of volume replacement during therapeutic leukapheresis on white blood cell reduction in patients with extreme leukocytosis. Transfusion 53:11, pages 2629-2634.
Crossref
Annemieke Leunis, W. Ken Redekop, Kees A. G. M. van Montfort, Bob L?wenberg & Carin A. Uyl-de Groot. (2013) The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid Leukemia. PharmacoEconomics 31:7, pages 605-621.
Crossref
Fuad El RassiMartha Arellano. (2013) Update on Optimal Management of Acute Myeloid Leukemia. Clinical Medicine Insights: Oncology 7, pages CMO.S8528.
Crossref
Jonathan How, Jenna Sykes, Vikas Gupta, Karen W. L. Yee, Aaron D. Schimmer, Andre C. Schuh, Mark D. Minden, Suzanne Kamel‐Reid & Joseph M. Brandwein. (2012) Influence of FLT3‐internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate‐risk karyotype acute myeloid leukemia. Cancer 118:24, pages 6110-6117.
Crossref
Chezi Ganzel, Joanne Becker, Paul D. Mintz, Hillard M. Lazarus & Jacob M. Rowe. (2012) Hyperleukocytosis, leukostasis and leukapheresis: Practice management. Blood Reviews 26:3, pages 117-122.
Crossref
David Valcárcel, Pau Montesinos, Isabel Sánchez‐Ortega, Salut Brunet, Jordi Esteve, David Martínez‐Cuadrón, José M. Ribera, Mar Tormo, Javier Bueno, Rafael Duarte, Andrés Llorente, Juan Pio Torres, Ramón Guardia, Miguel A. Sanz & and Jorge Sierra. (2011) A scoring system to predict the risk of death during induction with anthracycline plus cytarabine‐based chemotherapy in patients with de novo acute myeloid leukemia. Cancer 118:2, pages 410-417.
Crossref
Chezi Ganzel & Jacob M. Rowe. (2011) Prognostic Factors in Adult Acute Leukemia. Hematology/Oncology Clinics of North America 25:6, pages 1163-1187.
Crossref
Martha Arellano, Leon Bernal-Mizrachi, Lin Pan, Mourad Tighiouart, Liliana Souza, Xiangxue Guo, Morgan McLemore, Lisa Lima, Susan Sunay, Leonard T. Heffner, Zhengjia Chen, Georgia Zhou Chen, Amelia Langston, Elliott Winton & H. Jean Khoury. (2011) Prognostic Significance of Leukopenia at the Time of Diagnosis in Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 11:5, pages 427-432.
Crossref
Allan Jiang, Hua Jiang, Joseph Brandwein, Suzanne Kamel-Reid & Hong Chang. (2011) Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation. Leukemia Research 35:4, pages 492-498.
Crossref
XIAOQING LI, JUAN LI, WEN DU, JIAHUA ZHANG, WEI LIU, XIANGJUN CHEN, HONGRUI LI, SHIANG HUANG & XIN LI. (2011) Relevance of immunophenotypes to prognostic subgroups of age, WBC, platelet count, and cytogenetics in de novo acute myeloid leukemia. APMIS 119:1, pages 76-84.
Crossref
Gil Cunha De Santis, Luciana Correa Oliveira de Oliveira, Lucas Gabriel Maltoni Romano, Benedito de Pina Almeida PradoJr.Jr., Belinda Pinto Simoes, Eduardo Magalhaes Rego, Dimas Tadeu Covas & Roberto Passetto Falcao. (2011) Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia. Journal of Clinical Apheresis 26:4, pages 181-185.
Crossref
L. C. O. Oliveira, L. G. M. Romano, B. P. A. Prado-Junior, D. T. Covas, E. M. Rego & G. C. De Santis. (2009) Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Medical Oncology 27:4, pages 1254-1259.
Crossref
Lei Zhi, Min Wang, Qing Rao, Fan Yu, Yingchang Mi & Jianxiang Wang. (2010) Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38−/CD123+ leukemic stem cells by chemotherapy-resistance. Cancer Letters 296:1, pages 65-73.
Crossref
Anders Wahlin, Rolf Billström, Ove Björ, Tomas Ahlgren, Michael Hedenus, Martin Höglund, Anders Lindmark, Berit Markevärn, Bo Nilsson, Bengt Sallerfors & Mats Brune. (2009) Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study. European Journal of Haematology 83:2, pages 99-107.
Crossref
Joseph J Kishel & Jeffrey Sivik. (2008) Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up. Journal of Oncology Pharmacy Practice 14:4, pages 189-193.
Crossref
Laura Marbello, Francesca Ricci, Anna Maria Nosari, Mauro Turrini, Guido Nador, Michele Nichelatti, Alessandra Tedeschi, Eleonora Vismara & Enrica Morra. (2008) Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature. Leukemia Research 32:8, pages 1221-1227.
Crossref
Maria M. Ho, Donna E. Hogge & Victor Ling. (2008) MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Experimental Hematology 36:4, pages 433-442.
Crossref
Roberta Riccioni, Daniela Diverio, Gualtiero Mariani, Sonia Buffolino, Viviana Riti, Ernestina Saulle, Eleonora Petrucci, Michele Cedrone, Francesco Lo-Coco, Robin Foà, Cesare Peschle & Ugo Testa. (2007) Expression of Tie-2 and Other Receptors for Endothelial Growth Factors in Acute Myeloid Leukemias Is Associated with Monocytic Features of Leukemic Blasts. Stem Cells 25:8, pages 1862-1871.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.